A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis. (2020)
Attributed to:
Defining the disturbance in cortical glutamate and GABA function in psychosis, its origins and consequences
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41398-020-01095-8
PubMed Identifier: 33257661
Publication URI: http://europepmc.org/abstract/MED/33257661
Type: Journal Article/Review
Volume: 10
Parent Publication: Translational psychiatry
Issue: 1
ISSN: 2158-3188